Every September, Childhood Cancer Awareness Month highlights the challenges faced by children and families affected by cancer, while also recognising the importance of research and innovation in developing new treatment options.
Every September, Childhood Cancer Awareness Month highlights the challenges faced by children and families affected by cancer, while also recognising the importance of research and innovation in developing new treatment options.
Among the most promising advances in recent years is the CAR-T cell therapy, a personalised immunotherapy that uses a patient’s own immune cells to identify and attack cancer cells. For some children with certain types of leukemia, especially when standard treatments have not been successful, CAR-T therapy can offer a valuable therapeutic alternative.
Despite its potential, access to CAR-T therapies remains limited in many countries due to the highly specialized expertise and infrastructure required for their development and production. That is why the MILenARI project was created: to help address this challenge across the Mediterranean region and facilitate the knowledge transfer among different hospitals. Led by Clínic-IDIBAPS in Spain, the project supports the transfer of CAR-T knowledge and technology to partner institutions, such as the American University of Beirut (AUB) in Lebanon, the King Hussein Cancer Center (KHCC) in Jordan, and the Ospedale Pediatrico Bambino Gesù in Italy, helping build the capacities needed to deliver these advanced therapies to patients in the future.
Through training, technology transfer, and scientific collaboration, the project aims to strengthen local expertise and infrastructure, laying out the foundations for broader access to CAR-T therapies across the region.
On this Childhood Cancer Awareness Month, MILenARI reaffirms its commitment to international collaboration and innovation, supporting efforts to make advanced cell therapies more accessible to children with leukemia and their families throughout the Mediterranean.
Learn more here about how MILenARI is helping bring CAR-T therapies closer to children with leukemia.
Last Update
15/09/2026
Next Med